Literature DB >> 12901784

Neuropsychological deficits associated with Alzheimer's disease in the very-old: discrepancies in raw vs. standardized scores.

Mark W Bondi1, Wes S Houston, David P Salmon, Jody Corey-Bloom, Robert Katzman, Leon J Thal, Dean C Delis.   

Abstract

The profiles of neuropsychological deficits associated with Alzheimer's disease (AD) in Young-Old (M age and 70) and Very-Old (M age > 80) patients were compared, along with possible modifying effects of apolipoprotein E (APOE) genotype on these profiles. A comprehensive battery of neuropsychological tests was administered to the two AD patient groups (Young-Old: n = 33; Very-Old: n = 48) and their respective age-matched normal control (NC) groups who remained free of dementia on follow-up examinations over a 1 to 10 year period (Young-Old: n = 43; Very-Old: n = 36). AD and NC groups did not differ in education levels or gender distributions. Young-Old AD and Very-Old AD groups were comparable in education, gender, dementia severity, and disease duration. Results showed that both AD groups achieved comparable raw scores on all the neuropsychological measures. However, when scores were standardized on the basis of performance of their respective NC groups (i.e., age-corrected z scores), Very-Old AD patients significantly outperformed Young-Old AD patients on tests of executive functions, visuospatial skills, and delayed memory. Furthermore, the relationship between age and memory and executive function deficits in AD was modified by APOE genotype. These data suggest that the profile of neuropsychological deficits associated with AD in the Very-Old lacks the disproportionate saliency of episodic memory and executive function deficits typical of the Young-Old.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12901784      PMCID: PMC1621043          DOI: 10.1017/S1355617703950119

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  61 in total

1.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.

Authors:  C R Jack; R C Petersen; Y C Xu; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; S C Waring; E G Tangalos; E Kokmen
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

2.  The Oregon brain aging study: neuropathology accompanying healthy aging in the oldest old.

Authors:  M S Green; J A Kaye; M J Ball
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

3.  Decline in verbal memory during preclinical Alzheimer's disease: examination of the effect of APOE genotype.

Authors:  Kelly L Lange; Mark W Bondi; David P Salmon; Douglas Galasko; Dean C Delis; Ronald G Thomas; Leon J Thal
Journal:  J Int Neuropsychol Soc       Date:  2002-11       Impact factor: 2.892

4.  Quantitative synaptic alterations in the human neocortex during normal aging.

Authors:  E Masliah; M Mallory; L Hansen; R DeTeresa; R D Terry
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

5.  A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood.

Authors:  A Pfefferbaum; D H Mathalon; E V Sullivan; J M Rawles; R B Zipursky; K O Lim
Journal:  Arch Neurol       Date:  1994-09

6.  Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease.

Authors:  A Kurz; R Egensperger; M Haupt; N Lautenschlager; B Romero; M B Graeber; U Müller
Journal:  Neurology       Date:  1996-08       Impact factor: 9.910

7.  Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; J B Rimmler; P A Locke; P M Conneally; K E Schmader; R E Tanzi
Journal:  Neurology       Date:  1995-07       Impact factor: 9.910

8.  Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.

Authors:  T Gomez-Isla; H L West; G W Rebeck; S D Harr; J H Growdon; J J Locascio; T T Perls; L A Lipsitz; B T Hyman
Journal:  Ann Neurol       Date:  1996-01       Impact factor: 10.422

9.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

Review 10.  The functional neuroanatomy of episodic memory: the role of the frontal lobes, the hippocampal formation, and other areas.

Authors:  B Desgranges; J C Baron; F Eustache
Journal:  Neuroimage       Date:  1998-08       Impact factor: 6.556

View more
  14 in total

1.  Distinct profiles of brain and cognitive changes in the very old with Alzheimer disease.

Authors:  N H Stricker; Y-L Chang; C Fennema-Notestine; L Delano-Wood; D P Salmon; M W Bondi; A M Dale
Journal:  Neurology       Date:  2011-08-10       Impact factor: 9.910

2.  Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study.

Authors:  Giorgos Karas; Philip Scheltens; Serge Rombouts; Ronald van Schijndel; Martin Klein; Bethany Jones; Wiesje van der Flier; Hugo Vrenken; Frederik Barkhof
Journal:  Neuroradiology       Date:  2007-10-23       Impact factor: 2.804

Review 3.  Neuropsychological contributions to the early identification of Alzheimer's disease.

Authors:  Mark W Bondi; Amy J Jak; Lisa Delano-Wood; Mark W Jacobson; Dean C Delis; David P Salmon
Journal:  Neuropsychol Rev       Date:  2008-03-18       Impact factor: 7.444

Review 4.  Neuropsychological assessment of dementia.

Authors:  David P Salmon; Mark W Bondi
Journal:  Annu Rev Psychol       Date:  2009       Impact factor: 24.137

5.  FAS and CFL forms of verbal fluency differ in difficulty: a meta-analytic study.

Authors:  Danielle Barry; Marsha E Bates; Erich Labouvie
Journal:  Appl Neuropsychol       Date:  2008

6.  Functional connectivity during recognition memory in individuals genetically at risk for Alzheimer's disease.

Authors:  Lori Haase; MiRan Wang; Erin Green; Claire Murphy
Journal:  Hum Brain Mapp       Date:  2011-11-18       Impact factor: 5.038

7.  Selection of Normative Group Affects Rates of Mild Cognitive Impairment in Parkinson's Disease.

Authors:  Kathryn A Wyman-Chick; Phillip K Martin; Daniel Weintraub; Scott A Sperling; Lauren O Erickson; Carol A Manning; Matthew J Barrett
Journal:  Mov Disord       Date:  2018-02-14       Impact factor: 10.338

8.  APOE Affects the Volume and Shape of the Amygdala and the Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease: Age Matters.

Authors:  Xiaoying Tang; Dominic Holland; Anders M Dale; Michael I Miller
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

9.  APOE interacts with age to modify rate of decline in cognitive and brain changes in Alzheimer's disease.

Authors:  Yu-Ling Chang; Christine Fennema-Notestine; Dominic Holland; Linda K McEvoy; Nikki H Stricker; David P Salmon; Anders M Dale; Mark W Bondi
Journal:  Alzheimers Dement       Date:  2013-07-27       Impact factor: 21.566

10.  Neuropsychological Criteria for Mild Cognitive Impairment in the Framingham Heart Study's Old-Old.

Authors:  Christina G Wong; Kelsey R Thomas; Emily C Edmonds; Alexandra J Weigand; Katherine J Bangen; Joel S Eppig; Amy J Jak; Sherral A Devine; Lisa Delano-Wood; David J Libon; Steven D Edland; Rhoda Au; Mark W Bondi
Journal:  Dement Geriatr Cogn Disord       Date:  2018-11-02       Impact factor: 2.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.